87 related articles for article (PubMed ID: 20125044)
1. Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit.
Bayliss EA; Ellis JL; Delate T; Steiner JF; Raebel MA
Med Care; 2010 Mar; 48(3):267-72. PubMed ID: 20125044
[TBL] [Abstract][Full Text] [Related]
2. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
Raebel MA; Delate T; Ellis JL; Bayliss EA
Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
[TBL] [Abstract][Full Text] [Related]
3. Assessment of drug consumption patterns for Medicare Part D patients.
Pedan A; Lu J; Varasteh LT
Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
[TBL] [Abstract][Full Text] [Related]
4. Part D plan enrollment by uninsured medicare beneficiaries.
Maciejewski ML; Farley JF; Hansen RA; Wei D; Harman JS
Med Care; 2010 Feb; 48(2):183-6. PubMed ID: 20057332
[TBL] [Abstract][Full Text] [Related]
5. The Medicare Part D doughnut hole: effect on pharmacy utilization.
Sun SX; Lee KY
Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
[TBL] [Abstract][Full Text] [Related]
6. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
[TBL] [Abstract][Full Text] [Related]
7. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
8. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
[TBL] [Abstract][Full Text] [Related]
9. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
[TBL] [Abstract][Full Text] [Related]
10. How disease burden influences medication patterns for Medicare beneficiaries: implications for policy.
Stuart BC
Issue Brief (Commonw Fund); 2008 Feb; 30():1-12. PubMed ID: 18360960
[TBL] [Abstract][Full Text] [Related]
11. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
Starner CI; Norman SA; Reynolds RG; Gleason PP
Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
[TBL] [Abstract][Full Text] [Related]
12. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
Federman AD; Halm EA; Siu AL
Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
[TBL] [Abstract][Full Text] [Related]
13. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
14. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
Polinski JM; Mohr PE; Johnson L
Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
[TBL] [Abstract][Full Text] [Related]
15. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
[TBL] [Abstract][Full Text] [Related]
16. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey.
Lundy J; Craig BM
Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
Welch EK; Delate T; Chester EA; Stubbings T
Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
[TBL] [Abstract][Full Text] [Related]
18. Cost minimization of medicare part D prescription drug plan expenditures.
Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
[TBL] [Abstract][Full Text] [Related]
19. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
[TBL] [Abstract][Full Text] [Related]
20. Potential impact of Medicare Part D in the end-stage renal disease population.
St Peter WL
Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
